Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Tobacco Virus Protects Against Parkinson’s Disease

By BiotechDaily International staff writers
Posted on 15 Apr 2013
Print article
A virus typically associated with tobacco, but also present in spinach, tomatoes, petunias, and other household plants and vegetables, may help protect people from Parkinson’s disease.

Researchers from the University of Louisville’s (UofL; KY, USA) departments of neurology and physiology in a study published on April 3, 2013, in the journal PLOS One revealed that men who smoke have antibodies to the tobacco mosaic virus (TMV). These antibodies may interact with a protein in a cell’s energy generation system and inhibit the development of Parkinson’s disease.

Significantly, according to the researchers, this is the first reporting of the presence of antibodies to TMV in humans. Ruolan Liu, MD, PhD, Radhika Vaishnav, PhD, Andrew Roberts, PhD, and Robert Friedland, MD, examined blood samples of 60 men, 20 each who were smokeless tobacco users, smokers, or non-tobacco users. The researchers found the highest levels of the antibodies to TMV in those who smoked.

“It is quite remarkable that a plant that creates so many health problems for people may harbor a virus that has a protective role for people,” remarked Dr. Friedland, professor of neurology at the University of Louisville and the senior author for the study. “We still have a significant amount of research to undertake to determine what mechanisms may be involved, the molecular pathways that are in play and much more. However, it is valuable to consider the potential implications of plant viruses to human health and disease.”

Related Links:
University of Louisville



Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.